Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective chemical vestibulectomy.

C H Norris1, R G Amedee, J A Risey

  • 1Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine, New Orleans, Louisiana.

The American Journal of Otology
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor of trachea.

Memphis medical journal·2010
Same author

Brain abscess.

Memphis medical journal·2010
Same author

Management of fractures into the nasal sinuses.

The Laryngoscope·2010
Same author

The pathology of nasal polyps.

Archives of otolaryngology·2010
Same author

Allergic parotitis.

The Journal of allergy·2010
Same author

Intranasal surgery.

Surgery, gynecology & obstetrics·2010
Same journal

Conservative facial nerve management in jugular foramen schwannomas.

The American journal of otology·2000
Same journal

Histopathology of Ménière's disease.

The American journal of otology·2000
Same journal

Fibrous dysplasia of the temporal bone.

The American journal of otology·2000
Same journal

The history of the microscope for use in ear surgery.

The American journal of otology·2000
Same journal

Cerebellopontine angle involvement by nasopharyngeal carcinoma.

The American journal of otology·2000
Same journal

Practical aspects for optimal registration (matching) on the lateral skull base with an optical frameless computer-aided pointer system.

The American journal of otology·2000
See all related articles

Selective chemical vestibulectomy (SCV) uses streptomycin to target the vestibular labyrinth for intractable vertigo in Meniere's disease. A refined dose preserves hearing while effectively reducing vertigo symptoms.

Area of Science:

  • Otolaryngology
  • Neurosurgery
  • Pharmacology

Background:

  • Meniere's disease causes intractable vertigo.
  • Selective destruction of the vestibular labyrinth is a treatment goal.
  • Current treatments may have limitations.

Purpose of the Study:

  • To detail the development and clinical application of selective chemical vestibulectomy (SCV).
  • To evaluate the efficacy and safety of SCV in Meniere's disease patients with intractable vertigo.

Main Methods:

  • Animal models were used to determine the optimal streptomycin dose for vestibular ablation.
  • Streptomycin was introduced into the bony labyrinth via fenestration of the horizontal semicircular canal.
  • Clinical application involved 15 patients with Meniere's disease who failed conventional therapy.

Related Experiment Videos

Main Results:

  • Animal studies showed streptomycin could ablate vestibular end-organs without cochlear damage at 250 micrograms.
  • Initial human trials with 250 micrograms were excessive; a reduced dose of 125 micrograms is now used.
  • Patients treated with 125 micrograms maintained or improved their preoperative hearing thresholds.

Conclusions:

  • Selective chemical vestibulectomy (SCV) is a promising treatment for intractable vertigo in Meniere's disease.
  • Careful dose titration of streptomycin is crucial to preserve hearing function.
  • Further research is warranted to confirm the long-term efficacy and safety of SCV.